Somani, Sulaiman
Balla, Sujana
Peng, Allison W. http://orcid.org/0000-0002-1801-6815
Dudum, Ramzi
Jain, Sneha
Nasir, Khurram
Maron, David J. http://orcid.org/0000-0002-4867-8588
Hernandez-Boussard, Tina http://orcid.org/0000-0001-6553-3455
Rodriguez, Fatima http://orcid.org/0000-0002-5226-0723
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1K01HL144607)
Doris Duke Charitable Foundation (2022051)
American Heart Association/Harold Amos Medical Faculty Development Program
Article History
Received: 17 November 2023
Accepted: 7 March 2024
First Online: 30 March 2024
Competing interests
: F.R. reports consulting relationships with Healthpals, Novartis, NovoNordisk (CEC), Movano Health, Esperion Therapeutics, Kento Health, Inclusive Health, Arrowhead Pharmaceuticals, HeartFlow, and Edwards outside the submitted work. The remaining authors declare no competing interests.